Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Daniel Lee

Daniel Lee


Academic history

Daniel Lee, MD, completed his medical training followed by a residency at the University of Texas Health Science Center in TX. Dr Lee then completed a combined pediatric hematology and oncology fellowship training program at the National Cancer Institute, Pediatric Oncology Branch (POB), and Johns Hopkins University. He stayed on as an Assistant Clinical Investigator at POB for three years, before joining the University of Virginia faculty as an Assistant Professor.

Speaking on CAR T-cell therapy

Dr Lee was among the first in the world to treat children with lymphoblastic leukemia and B-cell lymphomas with chimeric antigen receptor (CAR) T-cell therapy. Since then, Dr Lee’s laboratory has developed several new CAR-T therapies for patients with leukemia and pediatric brain tumors and Dr Lee is the Principal Investigator on multiple immunotherapy trials in this area.

In addition, Dr Lee was instrumental in the redefinition of the grading system of cytokine release syndrome (CRS), which is a common side effect of CAR-T Therapy.